Back
Xeris Biopharma Holdings, Inc. Vs. Bowman Consulting Group Ltd. Industry Stock Comparison
Buy
59
XERS
Xeris Biopharma Holdings, Inc.
Last Price:
$6.04
Seasonality Move:
11.4%
Sell
44
BWMN
Bowman Consulting Group Ltd.
Last Price:
$29.63
Seasonality Move:
1.39%
Buy
59
Xeris Biopharma Holdings, Inc. (XERS)
is a Buy
Is Xeris Biopharma Holdings, Inc. a Buy, Sell or Hold?
-
The current Xeris Biopharma Holdings, Inc. [XERS] share price is $6.04. The Score for XERS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
XERS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Bowman Consulting Group Ltd. (BWMN)
is a Sell
Is Bowman Consulting Group Ltd. a Buy, Sell or Hold?
-
The current Bowman Consulting Group Ltd. [BWMN] share price is $29.65. The Score for BWMN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
BWMN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XERS Stock Price Chart
What is Xeris Biopharma Holdings, Inc.'s stock price today?
-
The Xeris Biopharma Holdings, Inc. share price today is $6.04The current trend is relatively stagnant and XERS is experiencing slight buying pressure.
BWMN Stock Price Chart
What is Bowman Consulting Group Ltd.'s stock price today?
-
The Bowman Consulting Group Ltd. share price today is $29.65The current trend is relatively stagnant and BWMN is experiencing buying pressure, which is a positive indicator for future bullish movement.
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 54.09 | Buy |
| Chaikin Money Flow: | 308943 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.43 - 5.95) | Buy |
| Bollinger Bands (100): | (6.08 - 7.52) | Sell |
BWMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 49.61 | Sell |
| Chaikin Money Flow: | 51978 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.4 - 31.18) | Buy |
| Bollinger Bands (100): | (30.57 - 35.89) | Sell |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.63 | Buy |
| 20-day SMA: | 5.61 | Buy |
| 50-day SMA: | 6.37 | Sell |
| 200-day SMA: | 6.94 | Sell |
| 8-day EMA: | 5.75 | Buy |
| 20-day EMA: | 5.77 | Buy |
| 50-day EMA: | 6.22 | Sell |
| 200-day EMA: | 6.47 | Sell |
BWMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.98 | Buy |
| 20-day SMA: | 28.55 | Buy |
| 50-day SMA: | 31.74 | Sell |
| 200-day SMA: | 35.62 | Sell |
| 8-day EMA: | 28.94 | Buy |
| 20-day EMA: | 29.27 | Buy |
| 50-day EMA: | 31.11 | Sell |
| 200-day EMA: | 33.16 | Sell |
Xeris Biopharma Holdings, Inc. Earnings Growth & XERS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.08 per share, and an increase next year of $0.23 per share.
Bowman Consulting Group Ltd. Earnings Growth & BWMN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.09 per share, and an increase next year of $0.56 per share.
Xeris Biopharma Holdings, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bowman Consulting Group Ltd. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||